Global /United States /Healthcare /Medical Devices /AIFF

Firefly Neuroscience, Inc.

AIFF

• NASDAQ: AIFF • Delayed

1.98USD -6.6%

As of 13 June 2026, Firefly Neuroscience, Inc. has a market cap of $29.29M USD, ranking #34397 globally and #4798 in the United States. It ranks #3101 in the Healthcare sector, and #654 in the Medical Devices industry.

Global Rank

34397

Country Rank

4798

Sector Rank

3101

Industry Rank

654

Key Stats

Market Cap

$29.29MUSD

Enterprise Value

$28.61MUSD

Revenue (TTM)

$1.14MUSD

EBITDA (TTM)

-$8.46MUSD

Net Income (TTM)

-$24.53MUSD

PS Ratio

27.5

PB Ratio

3.9

Company Profile

Country (HQ)

United States

Sector

Healthcare

Industry

Medical Devices

CEO

Greg Lipschitz open_in_new

Employees

Founded

2006

Website

fireflyneuro.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-6.6%	-11%	-9.2%	109%	3.1%	126%	-40%	-85%	-98%

News

AIFF Analyst Forecasts

Markets

Exchange	Ticker	Price	Quotes
NASDAQ MIC: XNAS PRIMARY	AIFF Firefly Neuroscience Inc ISIN: US3179701012 Shares Out.: Shares Outstanding: 15.572M¹ Shares Float: 13.382M² TV: TradingView: NASDAQ: AIFF SA: Stock Analysis: NASDAQ: AIFF YF: Yahoo Finance: AIFF GF: Google Finance: NASDAQ: AIFF NQ: NASDAQ: AIFF BA: Barron's: AIFF MS: Morningstar: XNAS: AIFF	1.98 USD	TV: TradingView: NASDAQ: AIFF SA: Stock Analysis: NASDAQ: AIFF YF: Yahoo Finance: AIFF GF: Google Finance: NASDAQ: AIFF NQ: NASDAQ: AIFF BA: Barron's: AIFF MS: Morningstar: XNAS: AIFF

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Firefly Neuroscience, Inc.

Firefly Neuroscience, Inc., a medical technology and artificial intelligence company, provides neuroscientific solutions that improve brain health outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. It serves pharmaceutical companies and medical practitioners. Firefly Neuroscience, Inc. was founded in 2006 and is based in Kenmore, New York.

Similar Companies

Industry: Medical Devices (United States)

Name	Market Cap (USD) diff.	PE	Country
Thermo Fisher Scientific Inc. NYSE: TMO	$173.27B 591K%	25.8	United States
Intuitive Surgical, Inc. NASDAQ: ISRG	$160.73B 549K%	56.7	United States
Abbott Laboratories NYSE: ABT	$159.07B 543K%	25.6	United States
Danaher Corp. NYSE: DHR	$126.55B 432K%	34.7	United States
Stryker Corp. NYSE: SYK	$120.69B 412K%	38.3	United States
Boston Scientific Corp. NYSE: BSX	$84.93B 290K%	24.5	United States

Industry: Medical Devices (Global)

Name	Market Cap (USD) diff.	PE	Country
Medtronic plc NYSE: MDT	$101.9B 348K%	22.2	Ireland
EssilorLuxottica Société anonyme EPA: EL	$97.46B 84.32B EUR 333K%	36.7	France
HOYA Corp. TSE: 7741	$61.41B 9.83T JPY 210K%	40.0	Japan
Siemens Healthineers AG XETRA: SHL	$45.47B 39.34B EUR 155K%	18.7	Germany
Alcon Inc. SIX: ALC	$36.38B 28.99B CHF 124K%	37.9	Switzerland
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. SHE: 300760	$30.06B 203.66B CNY 103K%	26.0	China

chevron_leftBack